iTeos Therapeutics, Inc. (DELISTED) (ITOS:DL)
10.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 05, 16:00
iTeos Therapeutics Net Income (Quarterly) : -78.73M for June 30, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | -78.73M |
| March 31, 2025 | -34.61M |
| December 31, 2024 | -43.71M |
| September 30, 2024 | -45.36M |
| June 30, 2024 | -7.128M |
| March 31, 2024 | -38.22M |
| December 31, 2023 | -30.55M |
| September 30, 2023 | -32.24M |
| June 30, 2023 | -34.30M |
| March 31, 2023 | -15.55M |
| December 31, 2022 | 20.45M |
| September 30, 2022 | 0.991M |
| Date | Value |
|---|---|
| June 30, 2022 | 5.626M |
| March 31, 2022 | 69.58M |
| December 31, 2021 | 184.87M |
| September 30, 2021 | 69.64M |
| June 30, 2021 | -26.46M |
| March 31, 2021 | -13.53M |
| December 31, 2020 | -14.90M |
| September 30, 2020 | -10.68M |
| June 30, 2020 | -7.202M |
| March 31, 2020 | -5.247M |
| March 31, 2019 | -4.402M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ZimVie, Inc. (DELISTED) | -3.848M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Black Titan Corp. | -0.43M |
| Solid Biosciences, Inc. | -54.80M |
| Replimune Group, Inc. | -69.77M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 78.73M |
| EPS Diluted (Quarterly) | -1.807 |
| Enterprise Value | -61.62M |
| Earnings Yield | -46.21% |
| Normalized Earnings Yield | -47.83 |